Protagonist Therapeutics' Series B Round

Protagonist Therapeutics raised a round of funding on June 04, 2013.

Protagonist Therapeutics is a biotechnology company pursuing the discovery and development of target oral peptides as well differentiated alternatives to antibodies, and also as new chemical entities …

Articles about Protagonist Therapeutics' Series B Round: